Effect of anti-podoplanin antibody administration during lipopolysaccharide-induced lung injury in mice

Sian Lax; Julie Rayes; David R Thickett; Steve P Watson

doi:10.1136/bmjresp-2017-000257

Article info

PDF

Critical care

Effect of anti-podoplanin antibody administration during lipopolysaccharide-induced lung injury in mice

Authors

Sian Lax Institute of Cardiovascular Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK PubMed articles Google scholar articles
Julie Rayes Institute of Cardiovascular Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK PubMed articles Google scholar articles
David R Thickett Institute of Inflammation and Ageing, University of Birmingham Research Labs, QE Hospital, Birmingham, UK PubMed articles Google scholar articles
Steve P Watson Institute of Cardiovascular Science, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK PubMed articles Google scholar articles

Correspondence to Dr Sian Lax; s.lax{at}bham.ac.uk

View Full Text

Citation

Lax S, Rayes J, Thickett DR, et al

Effect of anti-podoplanin antibody administration during lipopolysaccharide-induced lung injury in mice

BMJ Open Respiratory Research 2017;4:e000257. doi: 10.1136/bmjresp-2017-000257

Publication history

Received October 24, 2017
Revised October 24, 2017
Accepted October 25, 2017
First published November 8, 2017.

Online issue publication

January 19, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/